Management of recurrent oral herpes simplex infections

References

1. • Langenberg A.G.
   • Corey L.
   • Ashley R.L.
   • Leong W.P.
   • Straus S.E.
   A prospective study of new infections with herpes simplex virus type 1 and type 2.
   N Engl J Med. 1999; 341: 1432-1438
   View in Article

   • Google Scholar
2. • Xu F.
   • Schillinger J.A.
   • Sternberg M.R.
   • Johnson R.E.
   • Lee F.K.
   • Nahmias A.J.
   • et al.
   Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994.
   J Infect Dis. 2002; 185: 1019-1024
   View in Article

   • Google Scholar
3. • Miller C.S.
   • Danaher R.J.
   • Jacob R.J.
   Molecular aspects of herpes simplex virus I latency, reactivation, and recurrence.
   Crit Rev Oral Biol Med. 1998; 9: 541-562
   View in Article

   • Google Scholar
4. • Openshaw H.
   • McNeill J.I.
   • Lin X.H.
   • Niland J.
   • Cantin E.M.
   Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia.
   J Med Virol. 1995; 46: 75-80
   View in Article

   • Google Scholar
5. • Syrjanen S.
   • Mikola H.
   • Nykanen M.
   • Hukkanen V.
   In vitro establishment of lytic and nonproductive infection by herpes simplex virus type 1 in three-dimensional keratinocyte culture.
   J Virol. 1996; 70: 6524-6528
   View in Article

   • Google Scholar
6. • Krone M.R.
   • Wald A.
   • Tabet S.R.
   • Paradise M.
   • Corey L.
   • Celum C.L.
   Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors.
   Clin Infect Dis. 2000; 30: 261-267
   View in Article

   • Google Scholar
7. • Miller C.S.
   • Avdiushko S.A.
   • Kryscio R.J.
   • Danaher R.J.
   • Jacob R.J.
   Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment.
   J Clin Microbiol. 2005; 43: 2173-2180
   View in Article

   • Google Scholar
8. • Knaup B.
   • Schunemann S.
   • Wolff M.H.
   Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
   Oral Microbiol Immunol. 2000; 15: 281-283
   View in Article

   • Google Scholar
9. • Kaufman H.E.
   • Azcuy A.M.
   • Varnell E.D.
   • Sloop G.D.
   • Thompson H.W.
   • Hill J.M.
   HSV-1 DNA in tears and saliva of normal adults.
   Invest Ophthalmol Vis Sci. 2005; 46: 241-247
   View in Article

   • Google Scholar
10. • Wald A.
    • Huang M.L.
    • Carrell D.
    • Selke S.
    • Corey L.
    Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.
    J Infect Dis. 2003; 188: 1345-1351
    View in Article

    • Google Scholar
11. • Lafferty W.E.
    • Coombs R.W.
    • Benedetti J.
    • Critchlow C.
    • Corey L.
    Recurrences after oral and genital herpes simplex virus infection.
    N Engl J Med. 1987; 316: 1444-1449
    View in Article

    • Google Scholar
12. • Sawtell N.M.
    • Poon D.K.
    • Tansky C.S.
    • Thompson R.L.
    The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation.
    J Virol. 1998; 72: 5343-5350
    View in Article

    • Google Scholar
13. • Wald A.
    • Ericsson M.
    • Krantz E.
    • Selke S.
    • Corey L.
    Oral shedding of herpes simplex virus type 2.
    Sex Transm Infect. 2004; 80: 272-276
    View in Article

    • Google Scholar
14. • Posavad C.M.
    • Wald A.
    • Hosken N.
    • Huang M.L.
    • Koelle D.M.
    • Ashley R.L.
    • et al.
    T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?.
    J Immunol. 2003; 170: 4380-4388
    View in Article

    • Google Scholar
15. • Valimaa H.
    • Waris M.
    • Hukkanen V.
    • Blankenvoorde M.F.
    • Nieuw Amerongen A.V.
    • Tenovuo J.
    Salivary defense factors in herpes simplex virus infection.
    J Dent Res. 2002; 81: 416-421
    View in Article

    • Google Scholar
16. • Stanberry L.R.
    • Cunningham A.L.
    • Mindel A.
    • Scott L.L.
    • Spruance S.K.
    • Aoki F.Y.
    • et al.
    Prospects for control of herpes simplex virus disease through immunization.
    Clin Infect Dis. 2000; 30: 549-566
    View in Article

    • Google Scholar
17. • Weathers D.R.
    • Griffin J.W.
    Intraoral ulcerations of recurrent herpes simplex and recurrent aphthae: two distinct clinical entities.
    J Am Dent Assoc. 1970; 81: 81-87
    View in Article

    • Google Scholar
18. • Murakami S.
    • Mizobuchi M.
    • Nakashiro Y.
    • Doi T.
    • Hato N.
    • Yanagihara N.
    Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle.
    Ann Intern Med. 1996; 124: 27-30
    View in Article

    • Google Scholar
19. • Baringer J.R.
    Herpes simplex virus and Bell palsy.
    Ann Intern Med. 1996; 124: 63-65
    View in Article

    • Google Scholar
20. • Furuta Y.
    • Fukuda S.
    • Chida E.
    • Takasu T.
    • Ohtani F.
    • Inuyama Y.
    • et al.
    Reactivation of herpes simplex virus type 1 in patients with Bell’s palsy.
    J Med Virol. 1998; 54: 162-166
    View in Article

    • Google Scholar
21. • Adour K.K.
    • Ruboyianes J.M.
    • Von Doersten P.G.
    • Byl F.M.
    • Trent C.S.
    • Quesenberry Jr, C.P.
    • et al.
    Bell’s palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial.
    Ann Otol Rhinol Laryngol. 1996; 105: 371-378
    View in Article

    • Google Scholar
22. • Axelsson S.
    • Lindberg S.
    • Stjernquist-Desatnik A.
    Outcome of treatment with valacyclovir and prednisone in patients with Bell’s palsy.
    Ann Otol Rhinol Laryngol. 2003; 112: 197-201
    View in Article

    • Google Scholar
23. • Sun Y.
    • Chan R.K.
    • Tan S.H.
    • Ng P.P.
    Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiforme by nested PCR.
    J Med Virol. 2003; 71: 423-428
    View in Article

    • Google Scholar
24. • Kokuba H.
    • Aurelian L.
    • Burnett J.
    Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions.
    J Invest Dermatol. 1999; 113: 808-815
    View in Article

    • Google Scholar
25. • Hedner E.
    • Vahlne A.
    • Kahnberg K.E.
    • Hirsch J.M.
    Reactivated herpes simplex virus infection as a possible cause of dry socket after tooth extraction.
    J Oral Maxillofac Surg. 1993; 51 (discussion 7-8): 370-376
    View in Article

    • Google Scholar
26. • Embil J.A.
    • Stephens R.G.
    • Manuel F.R.
    Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents.
    Can Med Assoc J. 1975; 113: 627-630
    View in Article

    • Google Scholar
27. • Young S.K.
    • Rowe N.H.
    • Buchanan R.A.
    A clinical study for the control of facial mucocutaneous herpes virus infections.
    Oral Surg Oral Med Oral Pathol. 1976; 41: 498-507
    View in Article

    • Google Scholar
28. • Ship I.I.
    • Brightman V.J.
    • Laster L.L.
    The patient with recurrent aphthous ulcers and the patient with recurrent herpes labialis: a study of two population samples.
    J Am Dent Assoc. 1967; 75: 645-654
    View in Article

    • Google Scholar
29. • Spruance S.L.
    • Overall Jr, J.C.
    • Kern E.R.
    • Krueger G.G.
    • Pliam V.
    • Miller W.
    The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    N Engl J Med. 1977; 297: 69-75
    View in Article

    • Google Scholar
30. • Raborn G.W.
    • Grace M.G.
    Recurrent herpes simplex labialis: selected therapeutic options.
    J Can Dent Assoc. 2003; 69: 498-503
    View in Article

    • Google Scholar
31. • Worrall G.
    Acyclovir in recurrent herpes labialis.
    BMJ. 1996; 312: 6
    View in Article

    • Google Scholar
32. • Kibrick S.
    • Katz A.S.
    Topical idoxuridine in recurrent herpes simplex.
    Ann N Y Acad Sci. 1970; 173: 83-89
    View in Article

    • Google Scholar
33. • Marks R.
    • Koutts J.
    Topical treatment of recurrent herpes simplex with cytosine arabinoside.
    Med J Aust. 1975; 01: 479-480
    View in Article

    • Google Scholar
34. • Myers M.G.
    • Oxman M.N.
    • Clark J.E.
    • Arndt K.A.
    Failure of neutral-red photodynamic inactivation in recurrent herpes simplex virus infections.
    N Engl J Med. 1975; 293: 945-949
    View in Article

    • Google Scholar
35. • Taylor C.A.
    • Hendley J.O.
    • Greer K.E.
    • Gwaltney Jr, J.M.
    Topical treatment of herpes labialis with chloroform.
    Arch Dermatol. 1977; 113: 1550-1552
    View in Article

    • Google Scholar
36. • Guinan M.E.
    • MacCalman J.
    • Kern E.R.
    • Overall Jr, J.C.
    • Spruance S.L.
    Topical ether and herpes simplex labialis.
    JAMA. 1980; 243: 1059-1061
    View in Article

    • Google Scholar
37. • Milman N.
    • Scheibel J.
    • Jessen O.
    Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study.
    Acta Derm Venereol. 1980; 60: 85-87
    View in Article

    • Google Scholar
38. • Thein D.J.
    • Hurt W.C.
    Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis.
    Oral Surg Oral Med Oral Pathol. 1984; 58: 659-666
    View in Article

    • Google Scholar
39. • Rowe N.H.
    • Brooks S.L.
    • Young S.K.
    • Spencer J.
    • Petrick T.J.
    • Buchanan R.A.
    • et al.
    A clinical trial of topically applied 3 percent vidarabine against recurrent herpes labialis.
    Oral Surg Oral Med Oral Pathol. 1979; 47: 142-147
    View in Article

    • Google Scholar
40. • Gangarosa Sr, L.P.
    • Hill J.M.
    • Thompson B.L.
    • Leggett C.
    • Rissing J.P.
    Iontophoresis of vidarabine monophosphate for herpes orolabialis.
    J Infect Dis. 1986; 154: 930-934
    View in Article

    • Google Scholar
41. • Spruance S.L.
    • Krueger G.G.
    • MacCalman J.
    • Overall Jr, J.C.
    • Klauber M.R.
    Treatment of recurrent herpes simplex labialis with levamisole.
    Antimicrob Agents Chemother. 1979; 15: 662-665
    View in Article

    • Google Scholar
42. • Russell A.S.
    • Brisson E.
    • Grace M.
    A double-blind, controlled trial of levamisole in the treatment of recurrent herpes labialis.
    J Infect Dis. 1978; 137: 597-600
    View in Article

    • Google Scholar
43. • Spruance S.L.
    • Stewart J.C.
    • Rowe N.H.
    • McKeough M.B.
    • Wenerstrom G.
    • Freeman D.J.
    Treatment of recurrent herpes simplex labialis with oral acyclovir.
    J Infect Dis. 1990; 161: 185-190
    View in Article

    • Google Scholar
44. • Balfour Jr, H.H.
    Antiviral drugs.
    N Engl J Med. 1999; 340: 1255-1268
    View in Article

    • Google Scholar
45. • de Miranda P.
    • Blum M.R.
    Pharmacokinetics of acyclovir after intravenous and oral administration.
    J Antimicrob Chemother. 1983; 12: 29-37
    View in Article

    • Google Scholar
46. • Spruance S.L.
    • Schnipper L.E.
    • Overall Jr, J.C.
    • Kern E.R.
    • Wester B.
    • Modlin J.
    • et al.
    Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol.
    J Infect Dis. 1982; 146: 85-90
    View in Article

    • Google Scholar
47. • Fiddian A.P.
    • Ivanyi L.
    Topical acyclovir in the management of recurrent herpes labialis.
    Br J Dermatol. 1983; 109: 321-326
    View in Article

    • Google Scholar
48. • Raborn G.W.
    • McGaw W.T.
    • Grace M.
    • Percy J.
    Treatment of herpes labialis with acyclovir.
    Am J Med. 1988; 85: 39-42
    View in Article

    • Google Scholar
49. • Raborn G.W.
    • McGaw W.T.
    • Grace M.
    • Houle L.
    Herpes labialis treatment with acyclovir 5 per cent ointment.
    J Can Dent Assoc. 1989; 55: 135-137
    View in Article

    • Google Scholar
50. • Van Vloten W.A.
    • Swart R.N.
    • Pot F.
    Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.
    J Antimicrob Chemother. 1983; 12: 89-93
    View in Article

    • Google Scholar
51. • Fiddian A.P.
    • Yeo J.M.
    • Stubbings R.
    • Dean D.
    Successful treatment of herpes labialis with topical acyclovir.
    Br Med J (Clin Res Ed). 1983; 286: 1699-1701
    View in Article

    • Google Scholar
52. • Spruance S.L.
    • Nett R.
    • Marbury T.
    • Wolff R.
    • Johnson J.
    • Spaulding T.
    Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.
    Antimicrob Agents Chemother. 2002; 46: 2238-2243
    View in Article

    • Google Scholar
53. • Gibson J.R.
    • Klaber M.R.
    • Harvey S.G.
    • Tosti A.
    • Jones D.
    • Yeo J.M.
    Prophylaxis against herpes labialis with acyclovir cream—a placebo-controlled study.
    Dermatologica. 1986; 172: 104-107
    View in Article

    • Google Scholar
54. • Shaw M.
    • King M.
    • Best J.M.
    • Banatvala J.E.
    • Gibson J.R.
    • Klaber M.R.
    Failure of acyclovir cream in treatment of recurrent herpes labialis.
    Br Med J (Clin Res Ed). 1985; 291: 7-9
    View in Article

    • Google Scholar
55. • Raborn G.W.
    • McGaw W.T.
    • Grace M.
    • Percy J.
    • Samuels S.
    Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial.
    Oral Surg Oral Med Oral Pathol. 1989; 67: 676-679
    View in Article

    • Google Scholar
56. • Ottevanger V.
    • Larsen J.
    • Hoybye S.
    • Eskerod O.
    Efficacy of 86C (acyclovir) cream 5% compared with Zovirax (acyclovir) cream 5% in the treatment of recurrent herpes labialis.
    Curr Therap Res. 1996; 57: 243-250
    View in Article

    • Google Scholar
57. • Horwitz E.
    • Pisanty S.
    • Czerninski R.
    • Helser M.
    • Eliav E.
    • Touitou E.
    A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 87: 700-705
    View in Article

    • Google Scholar
58. • Evans T.G.
    • Bernstein D.I.
    • Raborn G.W.
    • Harmenberg J.
    • Kowalski J.
    • Spruance S.L.
    Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
    Antimicrob Agents Chemother. 2002; 46: 1870-1874
    View in Article

    • Google Scholar
59. • Spruance S.L.
    • Crumpacker C.S.
    • Schnipper L.E.
    • Kern E.R.
    • Marlowe E.S.
    • Arndt K.A.
    • et al.
    Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir.
    Antimicrob Agents Chemother. 1984; 25: 553-555
    View in Article

    • Google Scholar
60. • Freeman D.J.
    • Sheth N.V.
    • Spruance S.L.
    Failure of topical acyclovir in ointment to penetrate human skin.
    Antimicrob Agents Chemother. 1986; 29: 730-732
    View in Article

    • Google Scholar
61. • Trottet L.
    • Owen H.
    • Holme P.
    • et al.
    Are all aciclovir cream formulations bioequivalent?.
    Int J Pharm. 2005; 304: 63-71
    View in Article

    • Google Scholar
62. • Raborn G.W.
    • McGaw W.T.
    • Grace M.
    • Tyrrell L.D.
    • Samuels S.M.
    Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study.
    J Am Dent Assoc. 1987; 115: 38-42
    View in Article

    • Google Scholar
63. • Rooney J.F.
    • Straus S.E.
    • Mannix M.L.
    • Wohlenberg C.R.
    • Alling D.W.
    • Dumois J.A.
    • et al.
    Oral acyclovir to suppress frequently recurrent herpes labialis.
    Ann Intern Med. 1993; 118: 268-272
    View in Article

    • Google Scholar
64. • Spruance S.L.
    • Hamill M.L.
    • Hoge W.S.
    • Davis L.G.
    • Mills J.
    Acyclovir prevents reactivation of herpes simplex labialis in skiers.
    JAMA. 1988; 260: 1597-1599
    View in Article

    • Google Scholar
65. • Spruance S.L.
    • Freeman D.J.
    • Stewart J.C.
    • McKeough M.B.
    • Wenerstrom L.G.
    • Krueger G.G.
    • et al.
    The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir.
    J Infect Dis. 1991; 163: 728-734
    View in Article

    • Google Scholar
66. • Duteil L.
    • Queille-Roussel C.
    • Loesche C.
    • Verschoore M.
    Assessment of the effect of a sunblock stick in the prevention of solar-stimulating ultraviolet light-induced herpes labialis.
    J Dermatologic Treat. 1998; 9: 11-14
    View in Article

    • Google Scholar
67. • Rooney J.F.
    • Bryson Y.
    • Mannix M.L.
    • Dillon M.
    • Wohlenberg C.R.
    • Banks S.
    • et al.
    Prevention of ultraviolet-light-induced herpes labialis by sunscreen.
    Lancet. 1991; 338: 1419-1422
    View in Article

    • Google Scholar
68. • Raborn G.W.
    • Martel A.Y.
    • Grace M.G.
    • McGaw W.T.
    Oral acyclovir in prevention of herpes labialis.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 85: 55-59
    View in Article

    • Google Scholar
69. • Laiskonis A.
    • Thune T.
    • Neldam S.
    • Hiltunen-Back E.
    Valacyclovir in the treatment of facial herpes simplex virus infection.
    J Infect Dis. 2002; 186: S66-S70
    View in Article

    • Google Scholar
70. • Chosidow O.
    • Drouault Y.
    • Garraffo R.
    • Veyssier P.
    Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial.
    Br J Dermatol. 2003; 148: 142-146
    View in Article

    • Google Scholar
71. • Spruance S.L.
    • Jones T.M.
    • Blatter M.M.
    • Vargas-Cortes M.
    • Barber J.
    • Hill J.
    • et al.
    High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.
    Antimicrob Agents Chemother. 2003; 47: 1072-1080
    View in Article

    • Google Scholar
72. • Baker D.
    • Eisen D.
    Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Cutis. 2003; 71: 239-242
    View in Article

    • Google Scholar
73. • Miller C.S.
    • Cunningham L.L.
    • Lindroth J.E.
    • Avdiushko S.A.
    The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
    J Am Dent Assoc. 2004; 135: 1311-1318
    View in Article

    • Google Scholar
74. • Spruance S.L.
    Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.
    J Med Virol. 1993; : 27-32
    View in Article

    • Google Scholar
75. • Van Dyke R.B.
    • Connor J.D.
    • Wyborny C.
    • Hintz M.
    • Keeney R.E.
    Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis.
    Am J Med. 1982; 73: 172-175
    View in Article

    • Google Scholar
76. • Spruance S.L.
    • Kriesel J.D.
    • Evans T.G.
    • McKeough M.B.
    Susceptibility to herpes labialis following multiple experimental exposures to ultraviolet radiation.
    Antiviral Res. 1995; 28: 57-67
    View in Article

    • Google Scholar
77. • Hill T.J.
    • Blyth W.A.
    An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins.
    Lancet. 1976; 1: 397-399
    View in Article

    • Google Scholar
78. • Soul-Lawton J.
    • Seaber E.
    • On N.
    • Wootton R.
    • Rolan P.
    • Posner J.
    Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans.
    Antimicrob Agents Chemother. 1995; 39: 2759-2764
    View in Article

    • Google Scholar
79. • Weller S.
    • Blum M.R.
    • Doucette M.
    • Burnette T.
    • Cederberg D.M.
    • Doucette M.
    • et al.
    Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers.
    Clin Pharmacol Ther. 1993; 54: 595-605
    View in Article

    • Google Scholar
80. • Spruance S.L.
    • Wenerstrom G.
    Pathogenesis of recurrent herpes simplex labialis.
    Oral Surg Oral Med Oral Pathol. 1984; 58: 667-671
    View in Article

    • Google Scholar
81. • Tyring S.K.
    • Baker D.
    • Snowden W.
    Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years’ experience with acyclovir.
    J Infect Dis. 2002; 186: S40-S46
    View in Article

    • Google Scholar
82. • Boyd M.R.
    • Safrin S.
    • Kern E.R.
    Penciclovir: a review of the spectrum of activity, selectivity and cross resistance pattern.
    Antiviral Chem Chemother. 1993; 4: 3-11
    View in Article

    • Google Scholar
83. • Bacon T.H.
    • Levin M.J.
    • Leary J.J.
    • Sarisky R.T.
    • Sutton D.
    Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.
    Clin Microbiol Rev. 2003; 16: 114-128
    View in Article

    • Google Scholar
84. • Spruance S.L.
    • Rea T.L.
    • Thoming C.
    • Tucker R.
    • Saltzman R.
    • Boon R.
    Penciclovir cream for the treatment of herpes simplex labialis.
    JAMA. 1997; 277: 1374-1379
    View in Article

    • Google Scholar
85. • Raborn G.W.
    • Martel A.Y.
    • Lassonde M.
    • Lewis M.A.
    • Boon R.
    • Spruance S.L.
    Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
    J Am Dent Assoc. 2002; 133: 303-309
    View in Article

    • Google Scholar
86. • Boon R.
    • Goodman J.J.
    • Martinez J.
    • Marks G.L.
    • Gamble M.
    • Welch C.
    Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial.
    Clin Ther. 2000; 22: 76-90
    View in Article

    • Google Scholar
87. • Spruance S.L.
    • Tyring S.K.
    • Smith M.H.
    • Meng T.C.
    Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study.
    J Infect Dis. 2001; 184: 196-200
    View in Article

    • Google Scholar
88. • Spruance S.L.
    • McKeough M.B.
    Combination treatment with famciclovir and a topical corticosteroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study.
    J Infect Dis. 2000; 181: 1906-1910
    View in Article

    • Google Scholar
89. • Lin L.
    • Chen X.S.
    • Cui P.G.
    • Wang J.B.
    • Guo Z.P.
    • Lu N.Z.
    • et al.
    Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    J Dermatolog Treat. 2002; 13: 67-72
    View in Article

    • Google Scholar
90. • Femiano F.
    • Gombos F.
    • Scully C.
    Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir).
    Oral Dis. 2001; 7: 31-33
    View in Article

    • Google Scholar
91. • Spruance S.L.
    • Rowe N.H.
    • Raborn G.W.
    • Thibodeau E.A.
    • D’Ambrosio J.A.
    • Bernstein D.I.
    Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial.
    J Infect Dis. 1999; 179: 303-310
    View in Article

    • Google Scholar
92. • Katz D.H.
    • Marcelletti J.F.
    • Khalil M.H.
    • Pope L.E.
    • Katz L.R.
    Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex.
    Proc Natl Acad Sci U S A. 1991; 88: 10825-10829
    View in Article

    • Google Scholar
93. • Pope L.E.
    • Marcelletti J.F.
    • Katz L.R.
    • Lin J.Y.
    • Katz D.H.
    • Parish M.L.
    • et al.
    The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process.
    Antiviral Res. 1998; 40: 85-94
    View in Article

    • Google Scholar
94. • Habbema L.
    • De Boulle K.
    • Roders G.A.
    • Katz D.H.
    n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study.
    Acta Derm Venereol. 1996; 76: 479-481
    View in Article

    • Google Scholar
95. • Sacks S.L.
    • Thisted R.A.
    • Jones T.M.
    • Barbarash M.A.
    • Mikolich D.J.
    • Ruoff G.E.
    • et al.
    Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial.
    J Am Acad Dermatol. 2001; 45: 222-230
    View in Article

    • Google Scholar
96. • Lawee D.
    • Rosenthal D.
    • Aoki F.Y.
    • Portnoy J.
    Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    CMAJ. 1988; 138: 329-333
    View in Article

    • Google Scholar
97. • Bernstein D.I.
    • Schleupner C.J.
    • Evans T.G.
    • Blumberg D.A.
    • Bryson Y.
    • Grafford K.
    • et al.
    Effect of foscarnet cream on experimental UV radiation-induced herpes labialis.
    Antimicrob Agents Chemother. 1997; 41: 1961-1964
    View in Article

    • Google Scholar
98. • Tatnall F.M.
    • Schofield J.K.
    • Leigh I.M.
    A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme.
    Br J Dermatol. 1995; 132: 267-270
    View in Article

    • Google Scholar
99. • Kerob D.
    • Assier-Bonnet H.
    • Esnault-Gelly P.
    • Blanc F.
    • Saiag P.
    Recurrent erythema multiforme unresponsive to acyclovir prophylaxis and responsive to valacyclovir continuous therapy.
    Arch Dermatol. 1998; 134: 876-877
    View in Article

    • Google Scholar
100. • Greenberg M.S.
     • Cohen S.G.
     • Boosz B.
     • Friedman H.
     Oral herpes simplex infections in patients with leukemia.
     J Am Dent Assoc. 1987; 114: 483-486
     View in Article

     • Google Scholar
101. • Schubert M.M.
     • Peterson D.E.
     • Flournoy N.
     • Meyers J.D.
     • Truelove E.L.
     Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection.
     Oral Surg Oral Med Oral Pathol. 1990; 70: 286-293
     View in Article

     • Google Scholar
102. • Woo S.B.
     • Lee S.F.
     Oral recrudescent herpes simplex virus infection.
     Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 83: 239-243
     View in Article

     • Google Scholar
103. • Bergmann O.J.
     • Mogensen S.C.
     • Ellegaard J.
     Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies.
     Eur J Clin Microbiol Infect Dis. 1990; 9: 184-190
     View in Article

     • Google Scholar
104. • Montgomery M.T.
     • Redding S.W.
     • LeMaistre C.F.
     The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy.
     Oral Surg Oral Med Oral Pathol. 1986; 61: 238-242
     View in Article

     • Google Scholar
105. • Meyers J.D.
     • Flournoy N.
     • Thomas E.D.
     Infection with herpes simplex virus and cell-mediated immunity after marrow transplant.
     J Infect Dis. 1980; 142: 338-346
     View in Article

     • Google Scholar
106. • Stanberry L.R.
     • Floyd-Reising S.A.
     • Connelly B.L.
     • Alter S.J.
     • Gilchrist M.J.
     • Rubio C.
     • et al.
     Herpes simplex viremia: report of eight pediatric cases and review of the literature.
     Clin Infect Dis. 1994; 18: 401-407
     View in Article

     • Google Scholar
107. • Whitley R.J.
     • Levin M.
     • Barton N.
     • Hershey B.J.
     • Davis G.
     • Keeney R.E.
     • et al.
     Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy.
     J Infect Dis. 1984; 150: 323-329
     View in Article

     • Google Scholar
108. • Meyers J.D.
     • Wade J.C.
     • Mitchell C.D.
     • Saral R.
     • Lietman P.S.
     • Durack D.T.
     • et al.
     Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host.
     Am J Med. 1982; 73: 229-235
     View in Article

     • Google Scholar
109. • Shepp D.H.
     • Newton B.A.
     • Dandliker P.S.
     • Flournoy N.
     • Meyers J.D.
     Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
     Ann Intern Med. 1985; 102: 783-785
     View in Article

     • Google Scholar
110. • Mitchell C.D.
     • Bean B.
     • Gentry S.R.
     • Groth K.E.
     • Boen J.R.
     • Balfour Jr, H.H.
     Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients.
     Lancet. 1981; 1: 1389-1392
     View in Article

     • Google Scholar
111. • Saral R.
     • Burns W.H.
     • Laskin O.L.
     • Santos G.W.
     • Lietman P.S.
     Acyclovir prophylaxis of herpes-simplex-virus infections.
     N Engl J Med. 1981; 305: 63-67
     View in Article

     • Google Scholar
112. • Hann I.M.
     • Prentice H.G.
     • Blacklock H.A.
     • Ross M.G.
     • Brigden D.
     • Rosling A.E.
     • et al.
     Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
     Br Med J (Clin Res Ed). 1983; 287: 384-388
     View in Article

     • Google Scholar
113. • Gluckman E.
     • Lotsberg J.
     • Devergie A.
     • Zhao X.M.
     • Melo R.
     • Gomez-Morales M.
     • et al.
     Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir.
     Lancet. 1983; 2: 706-708
     View in Article

     • Google Scholar
114. • Wade J.C.
     • Newton B.
     • Flournoy N.
     • Meyers J.D.
     Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.
     Ann Intern Med. 1984; 100: 823-828
     View in Article

     • Google Scholar
115. • Saral R.
     • Ambinder R.F.
     • Burns W.H.
     • Angelopulos C.M.
     • Griffin D.E.
     • Burke P.J.
     • et al.
     Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia.
     Ann Intern Med. 1983; 99: 773-776
     View in Article

     • Google Scholar
116. • Liesveld J.L.
     • Abboud C.N.
     • Ifthikharuddin J.J.
     • Lancet J.E.
     • Wedow L.A.
     • Oliva J.
     • et al.
     Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.
     Biol Blood Marrow Transplant. 2002; 8: 662-665
     View in Article

     • Google Scholar
117. • Dignani M.C.
     • Mykietiuk A.
     • Michelet M.
     • Intile D.
     • Mammana L.
     • Desmery P.
     • et al.
     Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
     Bone Marrow Transplant. 2002; 29: 263-267
     View in Article

     • Google Scholar
118. • Eisen D.
     • Essell J.
     • Broun E.R.
     • Sigmund D.
     • DeVoe M.
     Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
     Bone Marrow Transplant. 2003; 31: 51-55
     View in Article

     • Google Scholar
119. • Orlowski R.Z.
     • Mills S.R.
     • Hartley E.E.
     • Ye X.
     • Piantadosi S.
     • Ambinder R.F.
     • et al.
     Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia.
     Leuk Lymphoma. 2004; 45: 2215-2219
     View in Article

     • Google Scholar
120. • Lazarus H.M.
     • Belanger R.
     • Candoni A.
     • Aoun M.
     • Jurewicz R.
     • Marks L.
     Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial.
     Antimicrob Agents Chemother. 1999; 43: 1192-1197
     View in Article

     • Google Scholar
121. • Redding S.W.
     • Luce E.B.
     • Boren M.W.
     Oral herpes simplex virus infection in patients receiving head and neck radiation.
     Oral Surg Oral Med Oral Pathol. 1990; 69: 578-580
     View in Article

     • Google Scholar
122. • Oakley C.
     • Epstein J.B.
     • Sherlock C.H.
     Reactivation of oral herpes simplex virus: implications for clinical management of herpes simplex virus recurrence during radiotherapy.
     Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84: 272-278
     View in Article

     • Google Scholar
123. • Schacker T.
     • Hu H.L.
     • Koelle D.M.
     • Zeh J.
     • Saltzman R.
     • Boon R.
     • et al.
     Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons.
     Ann Intern Med. 1998; 128: 21-28
     View in Article

     • Google Scholar
124. • Feinberg J.E.
     • Hurwitz S.
     • Cooper D.
     • Sattler F.R.
     • MacGregor R.R.
     • Powderly W.
     • et al.
     A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection.
     J Infect Dis. 1998; 177: 48-56
     View in Article

     • Google Scholar
125. • Dykewicz C.A.
     Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
     Clin Infect Dis. 2001; 33: 139-144
     View in Article

     • Google Scholar
126. • Gaudreau A.
     • Hill E.
     • Balfour Jr, H.H.
     • Erice A.
     • Boivin G.
     Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients.
     J Infect Dis. 1998; 178: 297-303
     View in Article

     • Google Scholar
127. • Morfin F.
     • Thouvenot D.
     Herpes simplex virus resistance to antiviral drugs.
     J Clin Virol. 2003; 26: 29-37
     View in Article

     • Google Scholar
128. • Englund J.A.
     • Zimmerman M.E.
     • Swierkosz E.M.
     • Goodman J.L.
     • Scholl D.R.
     • Balfour Jr, H.H.
     Herpes simplex virus resistant to acyclovir.
     Ann Intern Med. 1990; 112: 416-422
     View in Article

     • Google Scholar
129. • Danve-Szatanek C.
     • Aymard M.
     • Thouvenot D.
     • Morfin F.
     • Aqius G.
     • Bertin I.
     • et al.
     Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.
     J Clin Microbiol. 2004; 42: 242-249
     View in Article

     • Google Scholar
130. • Sarisky R.T.
     • Bacon T.H.
     • Boon R.J.
     • Duffy K.E.
     • Esser K.M.
     • Leary J.
     • et al.
     Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
     Arch Virol. 2003; 148: 1757-1769
     View in Article

     • Google Scholar
131. • Reusser P.
     • Cordonnier C.
     • Einsele H.
     • Engelhard D.
     • Link D.
     • Locasciulli A.
     • et al.
     European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients.
     Bone Marrow Transplant. 1996; 17: 813-817
     View in Article

     • Google Scholar
132. • Chen Y.
     • Scieux C.
     • Garrait V.
     • Socie G.
     • Rocha V.
     • Molina J.M.
     • et al.
     Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
     Clin Infect Dis. 2000; 31: 927-935
     View in Article

     • Google Scholar
133. • Lalezari J.
     • Schacker T.
     • Feinberg J.
     • Gathe J.
     • Lee S.
     • Cheung T.
     • et al.
     A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
     J Infect Dis. 1997; 176: 892-898
     View in Article

     • Google Scholar
134. • Williams-Aziz S.L.
     • Hartline C.B.
     • Harden E.A.
     • Daily S.L.
     • Prichard M.N.
     • Kushner N.L.
     • et al.
     Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.
     Antimicrob Agents Chemother. 2005; 49: 3724-3733
     View in Article

     • Google Scholar
135. • Lateef F.
     • Don P.C.
     • Kaufmann M.
     • White S.M.
     • Weinberg J.M.
     Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
     Arch Dermatol. 1998; 134: 1169-1170
     View in Article

     • Google Scholar
136. • Snoeck R.
     • Andrei G.
     • Gerard M.
     • Silverman A.
     • Hedderman A.
     • Balzarini J.
     • et al.
     Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
     Clin Infect Dis. 1994; 18: 570-578
     View in Article

     • Google Scholar
137. • Bryant P.
     • Sasadeusz J.
     • Carapetis J.
     • Waters K.
     • Curtis N.
     Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
     Pediatr Infect Dis J. 2001; 20: 1083-1086
     View in Article

     • Google Scholar
138. • Bernstein D.I.
     • Spruance S.L.
     • Arora S.S.
     • Schroeder J.L.
     • Meng T.C.
     Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
     Clin Infect Dis. 2005; 41: 808-814
     View in Article

     • Google Scholar
139. • Danielsen A.G.
     • Petersen C.S.
     • Iversen J.
     Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir.
     Br J Dermatol. 2002; 147: 1034-1036
     View in Article

     • Google Scholar
140. • Bernstein D.I.
     • Aoki F.Y.
     • Tyring S.K.
     • Stanberry L.R.
     • St-Pierre C.
     • Shafran S.D.
     • et al.
     Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine.
     Clin Infect Dis. 2005; 40: 1271-1281
     View in Article

     • Google Scholar
141. • Spruance S.L.
     • Stewart J.C.
     • Freeman D.J.
     • Brightman V.J.
     • Cox J.L.
     • Wenerstrom G.
     • et al.
     Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial.
     J Infect Dis. 1990; 161: 191-197
     View in Article

     • Google Scholar
142. • Shafran S.D.
     • Sacks S.L.
     • Aoki F.Y.
     • Tyrrell S.D.
     • Schlech 3rd, W.F.
     • Mendelson J.
     • et al.
     Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial.
     J Infect Dis. 1997; 176: 78-83
     View in Article

     • Google Scholar
143. • Bolla K.
     • Djawari D.
     • Kokoschka E.M.
     • Petres J.
     • Liden S.
     • Gonseth R.
     • et al.
     Prevention of recurrences in frequently relapsing herpes labialis with thymopentin.
     Surv Immunol Res. 1985; 4: 37-47
     View in Article

     • Google Scholar
144. • Cassady K.A.
     • Whitley R.J.
     New therapeutic approaches to the alphaherpesvirus infections.
     J Antimicrob Chemother. 1997; 39: 119-128
     View in Article

     • Google Scholar
145. • Rodu B.
     • Russell C.M.
     • Mattingly G.
     Determining therapeutic efficacy in recurrent herpes labialis by lesion size analysis.
     Oral Surg Oral Med Oral Pathol. 1991; 72: 178-183
     View in Article

     • Google Scholar
146. • Kaminester L.H.
     • Pariser R.J.
     • Pariser D.M.
     • Weiss J.S.
     • Shavin J.S.
     • Landsman L.
     • et al.
     A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis.
     J Am Acad Dermatol. 1999; 41: 996-1001
     View in Article

     • Google Scholar
147. • Koytchev R.
     • Alken R.G.
     • Dundarov S.
     Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis.
     Phytomedicine. 1999; 6: 225-230
     View in Article

     • Google Scholar
148. • Pedersen A.
     LongoVital and herpes labialis: a randomised, double-blind, placebo-controlled study.
     Oral Dis. 2001; 7: 221-225
     View in Article

     • Google Scholar
149. • Huleihel M.
     • Isanu V.
     Anti-herpes simplex virus effect of an aqueous extract of propolis.
     Isr Med Assoc J. 2002; 4: 923-927
     View in Article

     • Google Scholar
150. • Spruance S.L.
     • McKeough M.B.
     • Cardinal J.R.
     Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection.
     Antimicrob Agents Chemother. 1984; 25: 10-15
     View in Article

     • Google Scholar